IRMD, US4627231087

IRadimed Stock - Chart picture after recent pullback

17.06.2026 - 19:04:40 | ad-hoc-news.de

IRadimed shares have eased from recent highs, but the Nasdaq-listed medical device stock still trades near the upper end of its 12?month range. A look at the chart levels and volatility on this quiet Wednesday.

IRMD, US4627231087
IRMD, US4627231087

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 17:00 UTC. Details in the imprint.

IRadimed (US4627231087) develops MRI-compatible medical devices and its stock is trading quietly this Wednesday on Nasdaq without fresh corporate headlines from the company or major newswires. With no new filings or broker notes, the focus shifts to the chart picture and recent trading behavior.

Go deeper

All news and price data on IRadimed stock

Follow IRadimed stock, past corporate releases and intraday quotes with our continuously updated topic overview.

What the chart currently shows

IRadimed shares most recently changed hands around the low-$90 range on Nasdaq, after trading between roughly $91.01 and $93.69 during the latest session according to Robinhood data. That intraday span underlines modest but noticeable volatility in an otherwise news-light period.

The stock still sits relatively close to its recent 12-month high, even after a pullback of around 2-3% from short-term peaks reported earlier in the week. Against that backdrop, the current consolidation looks more like a pause after a strong run than a clear trend break.

Technical levels on this Wednesday

From a purely descriptive standpoint, the recent low-$90 area has emerged as near-term support, given repeated intraday bounces from just above $91 in recent trading. On the upside, the mid-$90 band marks the latest resistance zone where sellers have recently regained the upper hand.

Short-term traders are watching how IRadimed behaves around these levels, alongside broader healthcare and medical device names on the Standard & Poor's 500 index and Nasdaq. Option activity around the stock appears moderate, with a relatively thin options chain reported on MarketBeat.

The business behind the ticker

IRadimed generates its revenue by developing and selling MRI-compatible patient monitoring systems and intravenous infusion pumps designed specifically for use in magnetic resonance imaging suites. These systems allow clinicians to monitor patients continuously during scans without disrupting the MRI environment.

Where the stock trades today

The shares of IRadimed (US4627231087) last traded on Nasdaq at approximately $91.80 on 06/17/2026, 16:00 ET, based on delayed market data in US dollars.

Key facts on IRadimed stock

  • Company: IRadimed Corporation
  • ISIN: US4627231087
  • WKN: A12C0Z
  • Ticker: IRMD
  • Venue: Nasdaq
  • Price (as of 06/17/2026, 16:00 ET): 91.80 USD
  • Market cap: 1.17 billion USD (as of 06/17/2026)
  • Sector / Industry: Healthcare / Medical Devices
  • Index membership: not a member of major headline indices such as the S&P 500 or Nasdaq-100
  • Next earnings date: not officially scheduled

More on IRadimed stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US4627231087 | IRMD | boerse | 69565089 | bgmi